您好！歡迎訪問上海起發(fā)實驗試劑有限公司網(wǎng)站！
全國服務咨詢熱線:
15921799099
15921799099
產(chǎn)品編號：
62-0-78b
產(chǎn)品名稱：
ß-Amyloid (1-40)
規(guī)格型號：
1mg
生產(chǎn)廠家：
americanpeptide
*
American Peptide公司專注于為藥物研發(fā)和其他生命科學領域提供高品質(zhì)的多肽和蛋白質(zhì)研究產(chǎn)品和服務。公司提供的種類豐富的多肽，定制服務，及按GMP標準生產(chǎn)作為活性藥物成分的非專li多肽或定制多肽。公司提供的服務包括工藝開發(fā)，擴大生產(chǎn)、分析和工藝驗證，穩(wěn)定性研究，CMC，DMF。
以下目錄多肽每個產(chǎn)品類別包括多個產(chǎn)品，如細胞程序化死亡及相關多肽中的Caspase-1底物和抑制劑：
產(chǎn)品 | 貨號 | 來源 | 規(guī)格 |
Ac-VAD-CHO | 81-7-02A | Ac-Val-Ala-Asp-CHO | 1.0 mg |
Ac-VAD-CHO | 81-7-02B | Ac-Val-Ala-Asp-CHO | 5.0 mg |
Ac-YVAD-AMC | 81-7-30B | Ac-Tyr-Val-Ala-Asp-AMC | 5.0 mg |
Ac-YVAD-AMC | 81-7-30A | Ac-Tyr-Val-Ala-Asp-AMC | 1.0 mg |
Ac-YVAD-CHO | 81-7-31B | Ac-Tyr-Val-Ala-Asp-CHO | 5.0 mg |
Ac-YVAD-CHO | 81-7-31A | Ac-Tyr-Val-Ala-Asp-CHO | 1.0 mg |
Ac-YVAD-pNA | 81-7-34 | Ac-Tyr-Val-Ala-Asp-pNA | 1.0 mg |
Ac-YVKD-CMK | 81-7-3 | Ac-Tyr-Val-Ala-Asp-CMK | 0.5 mg |
Ac-YVKD-CMK | 81-7-35B | Ac-Tyr-Val-Ala-Asp-CMK | 1.0 mg |
Biotin-YVAD-CHO | 81-7-36A | Biotin-Tyr-Val-Ala-Asp-CHO | 0.5 mg |
Biotin-YVAD-CHO | 81-7-36B | Biotin-Tyr-Val-Ala-Asp-CHO | 1.0 mg |
Calpain Inhibitor Peptide | 81-5-40 | Asp-Pro-Met-Ser-Ser-Thr-Tyr-Ile-Glu-Glu-Leu-Gly-Lys-Arg-Glu-Val-Thr-Ile-Pro-Pro-Lys-Tyr-Arg-Glu-Leu-Leu-Ala | 0.5 mg |
Caspase-1 Inhibitor I, Cell-Permeable | 81-6-36A | Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Tyr-Val-Ala-Asp-CHO | 0.5 mg |
Caspase-1 Inhibitor I, Cell-Permeable | 81-6-36B | Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Tyr-Val-Ala-Asp-CHO | 1.0 mg |
Caspase-1 Inhibitor V | 81-7-06A | Z-Val-Ala-Asp(OMe)-fluoromethylketone | 0.5 mg |
Caspase-1 Inhibitor V | 81-7-06B | Z-Val-Ala-Asp(OMe)-fluoromethylketone | 1.0 mg |
Caspase-3 Subtrate Ac-Asp-Asn-Leu-Asp-AMC | 81-6-45 | Ac-Asp-Asn-Leu-Asp-AMC | 0.5 mg |
Caspase-7 Substrate I, Fluorogenic | 81-7-97A | Mca-Val-Asp-Gln-Val-Asp-Gly-Trp-Lys(Dnp)-NH2 | 0.5 mg |
Caspase-7 Substrate I, Fluorogenic | 81-7-97B | Mca-Val-Asp-Gln-Val-Asp-Gly-Trp-Lys(Dnp)-NH2 | 1.0 mg |
GSK-3β Peptide Inhibitor | 81-6-38A | Lys-Glu-Ala-Pro-Pro-Ala-Pro-Pro-Gln-Ser(PO3H)-Pro-NH2 | 0.5 mg |
GSK-3β Peptide Inhibitor | 81-6-38B | Lys-Glu-Ala-Pro-Pro-Ala-Pro-Pro-Gln-Ser(PO3H)-Pro-NH2 | 1.0 mg |
GSK-3β Peptide Inhibitor, Cell Permeable | 81-6-39A | Myr-N-Gly-Lys-Glu-Ala-Pro-Pro-Ala-Pro-Pro-Gln-Ser(PO3H)-Pro-NH2 | 0.5 mg |
GSK-3β Peptide Inhibitor, Cell Permeable | 81-6-39B | Myr-N-Gly-Lys-Glu-Ala-Pro-Pro-Ala-Pro-Pro-Gln-Ser(PO3H)-Pro-NH2 | 1.0 mg |
IL-1b Converting Enzyme (ICE) Inhibitor IV | 81-7-01 | Ac-Tyr-Val-Lys-Asp-CHO | 1.0 mg |
TNF-a (71-82), human | 81-1-12A | Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg | 0.5 mg |
TNF-a (71-82), human | 81-1-12B | Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg | 1.0 mg |
YVAD-CHO | 81-7-38A | Tyr-Val-Ala-Asp-CHO | 1.0 mg |
YVAD-CHO | 81-7-38B | Tyr-Val-Ala-Asp-CHO | 5.0 mg |
Z-Val-Ala-Asp-AMC | 81-7-85 | Z-Val-Ala-Asp-AMC | 1.0 mg |
部分淀粉樣蛋白和相關多肽產(chǎn)品：
ß-Amyloid (1-11) | 62-0-10A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu | 0.5 mg |
ß-Amyloid (1-11) | 62-0-10B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu | 1.0 mg |
ß-Amyloid (1-16), human | 62-0-36A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys | 0.5 mg |
ß-Amyloid (1-16), human | 62-0-36B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys | 1.0 mg |
ß-Amyloid (1-28) | 62-0-74B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | 1.0 mg |
ß-Amyloid (1-28) | 62-0-74A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | 0.5 mg |
ß-Amyloid (1-38) | 62-0-76A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly | 0.5 mg |
ß-Amyloid (1-38) | 62-0-76B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly | 1.0 mg |
ß-Amyloid (1-38), mouse, rat | 62-1-00A | Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly | 0.5 mg |
ß-Amyloid (1-38), mouse, rat | 62-1-00B | Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly | 1.0 mg |
ß-Amyloid (1-40) | 62-0-78A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 0.5 mg |
ß-Amyloid (1-40) | 62-0-78B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 1.0 mg |
ß-Amyloid (10-20) | 62-0-20A | Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe | 0.5 mg |
ß-Amyloid (10-20) | 62-0-20B | Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe | 1.0 mg |
ß-Amyloid (12-28) | 62-0-73A | Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | 0.5 mg |
ß-Amyloid (12-28) | 62-0-73B | Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | 1.0 mg |
ß-Amyloid (22-35) | 62-0-3 | Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met | 0.5 mg |
ß-Amyloid (22-35) | 62-0-35B | Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met | 1.0 mg |
ß-Amyloid (25-35) | 62-0-72A | Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met | 0.5 mg |
ß-Amyloid (25-35) | 62-0-72B | Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met | 1.0 mg |
ß-Amyloid (31-35) | 62-0-31A | Ile-Ile-Gly-Leu-Met | 1.0 mg |
ß-Amyloid (31-35) | 62-0-31B | Ile-Ile-Gly-Leu-Met | 5.0 mg |
ß-Amyloid (32-35) | 62-0-12 | Ile-Gly-Leu-Met | 1.0 mg |
ß-Amyloid (35-25) | 62-0-33A | Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly | 0.5 mg |
ß-Amyloid (35-25) | 62-0-33B | Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly | 1.0 mg |
ß-Amyloid (40-1) | 62-0-77 | Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp | 0.1 mg |
ß-Amyloid / A4 Protein Precursor (APP) (96-110), analog | 62-1-1 | Ac-Asn-Trp-Cys-Lys-Arg-Gly-Arg-Lys-Gln-Cys-Lys-Thr-His-Pro-His-NH2 | 0.5 mg |
ß-Amyloid / A4 Protein Precursor (APP) (96-110), analog | 62-1-15B | Ac-Asn-Trp-Cys-Lys-Arg-Gly-Arg-Lys-Gln-Cys-Lys-Thr-His-Pro-His-NH2 | 1.0 mg |
ß-Amyloid / A4 Protein Precusor (APP) (319-335) | 62-5-10A | Ala-Lys-Glu-Arg-Leu-Glu-Ala-Lys-His-Arg-Glu-Arg-Met-Ser-Gln-Val-Met | 0.5 mg |
ß-Amyloid / A4 Protein Precusor (APP) (319-335) | 62-5-10B | Ala-Lys-Glu-Arg-Leu-Glu-Ala-Lys-His-Arg-Glu-Arg-Met-Ser-Gln-Val-Met | 1.0 mg |
ßAmyloid BRI Peptide (1-34) | 62-0-92B | Glp-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Ser-Arg-Thr-Val-Lys-Lys-Asn-Ile-Ile-Glu-Glu-Asn | 1.0 mg |
ßAmyloid BRI Peptide (1-34) | 62-0-92A | Glp-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Ser-Arg-Thr-Val-Lys-Lys-Asn-Ile-Ile-Glu-Glu-Asn | 0.5 mg |
β-Amyloids (1-42), FAM - labeled | 62-1-01 | 5FAM-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | 0.1 mg |
β-Amyloid (1-40), amide | 62-0-6 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-NH2 | 0.5 mg |
β-Amyloid (1-40), amide | 62-0-65B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-NH2 | 1.0 mg |
β-Amyloid (1-40), rat | 62-0-86A | Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 0.5 mg |
β-Amyloid (1-40), rat | 62-0-86B | Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 1.0 mg |
β-Amyloid (1-42) | 62-0-80A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | 0.5 mg |
β-Amyloid (1-42) | 62-0-80B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | 1.0 mg |
β-Amyloid (1-43) | 62-0-83A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr | 0.5 mg |
β-Amyloid (1-43) | 62-0-83B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr | 1.0 mg |
β-Amyloid (17-28) | 62-0-13A | Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | 0.5 mg |
β-Amyloid (17-28) | 62-0-13B | Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | 1.0 mg |
β-Amyloid (33-42) | 62-0-22A | Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | 0.5 mg |
β-Amyloid (33-42) | 62-0-22B | Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | 1.0 mg |
(Glp3) b-Amyloid (3-42) | 62-0-21A | Glp-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | 0.5 mg |
(Glp3) b-Amyloid (3-42) | 62-0-21B | Glp-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | 1.0 mg |
Ac-Leu-Pro-Phe-Phe-Asp-NH2 | 62-0-18A | Ac-Leu-Pro-Phe-Phe-Asp-NH2 | 0.5 mg |
Ac-Leu-Pro-Phe-Phe-Asp-NH2 | 62-0-18B | Ac-Leu-Pro-Phe-Phe-Asp-NH2 | 1.0 mg |
Ac-Lys-N-Me-Leu-Val-N-Me-Phe-Phe-NH2 | 62-0-19A | Ac-Lys-(NMe)Leu-Val-(NMe)Phe-Phe-NH2 | 0.5 mg |
Ac-Lys-N-Me-Leu-Val-N-Me-Phe-Phe-NH2 | 62-0-19B | Ac-Lys-(NMe)Leu-Val-(NMe)Phe-Phe-NH2 | 1.0 mg |
Amyloid β-Protein (1-15) | 62-1-04A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln | 1.0 mg |
Amyloid β-Protein (1-15) | 62-1-04B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln | 5.0 mg |
Amyloid β-Protein (10-35) Trifluoroacetate | 62-1-03A | Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met | 1.0 mg |
Amyloid β-Protein (10-35) Trifluoroacetate | 62-1-03B | Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met | 5.0 mg |
Amyloid β-Protein (6-20) | 62-1-02B | His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe | 5.0 mg |
Amyloid β-Protein (6-20) | 62-1-02A | His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe | 1.0 mg |
Amyloid BRI Precursor277 (89-106) | 62-0-02A | Cys-Gly-Ile-Lys-Tyr-Ile-Lys-Asp-Asp-Val-Ile-Leu-Asn-Glu-Pro-Ser-Ala-Asp | 0.5 mg |
Amyloid BRI Precursor277 (89-106) | 62-0-02B | Cys-Gly-Ile-Lys-Tyr-Ile-Lys-Asp-Asp-Val-Ile-Leu-Asn-Glu-Pro-Ser-Ala-Asp | 1.0 mg |
Amyloid Dan Protein (1-34) | 62-0-04A | Glp-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Phe-Asn-Leu-Phe-Leu-Asn-Ser-Gln-Glu-Lys-His-Tyr | 0.5 mg |
Amyloid Dan Protein (1-34) | 62-0-04B | Glp-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Phe-Asn-Leu-Phe-Leu-Asn-Ser-Gln-Glu-Lys-His-Tyr | 1.0 mg |
Amyloid Precursor C-Terminal Peptide | 62-0-15B | Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn | 1.0 mg |
Amyloid Precursor C-Terminal Peptide | 62-0-1 | Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn | 0.5 mg |
Amyloid Precursor Frameshift Mutant C-Terminal Peptide | 81-3-10A | Arg-Gly-Arg-Thr-Ser-Ser-Lys-Glu-Leu-Ala | 0.5 mg |
Amyloid Precursor Frameshift Mutant C-Terminal Peptide | 81-3-10B | Arg-Gly-Arg-Thr-Ser-Ser-Lys-Glu-Leu-Ala | 1.0 mg |
Amyloid Precursor N-Terminal Peptide | 62-0-14A | His-Met-Asn-Val-Gln-Asn-Gly-Lys-Trp-Asp-Ser-Asp-Pro-Ser-Gly-Thr-Lys-Thr-Cys-Ile | 0.5 mg |
Amyloid Precursor N-Terminal Peptide | 62-0-14B | His-Met-Asn-Val-Gln-Asn-Gly-Lys-Trp-Asp-Ser-Asp-Pro-Ser-Gly-Thr-Lys-Thr-Cys-Ile | 1.0 mg |
b-Amyloid (10-35), amide | 62-0-16A | Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-NH2 | 0.5 mg |
b-Amyloid (10-35), amide | 62-0-16B | Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-NH2 | 1.0 mg |
b-Amyloid (17-40) | 62-0-8 | Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 0.5 mg |
b-Amyloid (17-40) | 62-0-85B | Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 1.0 mg |
b-Amyloid (42-1) | 62-0-81 | Ala-Ile-Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp | 0.1 mg |
Beta-Amyloid Peptide (1-42), mouse, rat | 62-0-84A | Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | 0.5 mg |
Beta-Amyloid Peptide (1-42), mouse, rat | 62-0-84B | Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | 1.0 mg |
Beta-Sheet Breaker Peptide iAβ5 | 62-0-06 | Leu-Pro-Phe-Phe-Asp | 1.0 mg |
Biotinylated-β-Amyloid (1-42) | 62-0-51A | Biotin-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | 0.5 mg |
Biotinylated-β-Amyloid (1-42) | 62-0-51B | Biotin-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | 1.0 mg |
Non-ß-Amyloid Component of Alzheimer’s Disease (NAC) | 62-5-25 | Glu-Gln-Val-Thr-Asn-Val-Gly-Gly-Ala-Val-Val-Thr-Gly-Val-Thr-Ala-Val-Ala-Gln-Lys-Thr-Val-Glu-Gly-Ala-Gly-Ser-Ile-Ala-Ala-Ala-Thr-Gly-Phe-Val | 0.1 mg |
Prion Protein (118-135), human | 62-0-00A | Ala-Gly-Ala-Val-Val-Gly-Gly-Leu-Gly-Gly-Tyr-Met-Leu-Gly-Ser-Ala-Met-Ser | 0.5 mg |
Prion Protein (118-135), human | 62-0-00B | Ala-Gly-Ala-Val-Val-Gly-Gly-Leu-Gly-Gly-Tyr-Met-Leu-Gly-Ser-Ala-Met-Ser | 1.0 mg |
[Arg13] b-Amyloid (1-40) | 62-0-27A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 0.5 mg |
[Arg13] b-Amyloid (1-40) | 62-0-27B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 1.0 mg |
[Arg22] b-Amyloid (1-40) | 62-0-87B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Arg-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 1.0 mg |
[Arg22] b-Amyloid (1-40) | 62-0-87A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Arg-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 0.5 mg |
[Asp22] b-Amyloid (1-40) | 62-0-88B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Asp-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 1.0 mg |
[Asp22] b-Amyloid (1-40) | 62-0-88A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Asp-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 0.5 mg |
[Cys] b-Amyloid (1-40) | 62-0-23A | Cys-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 0.5 mg |
[Cys] b-Amyloid (1-40) | 62-0-23B | Cys-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 1.0 mg |
[Gln11] ß-Amyloid (1-16) | 62-0-70A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys | 0.5 mg |
[Gln11] ß-Amyloid (1-16) | 62-0-70B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys | 1.0 mg |
[Gln11] ß-Amyloid (1-28) | 62-0-7 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | 0.5 mg |
[Gln11] ß-Amyloid (1-28) | 62-0-75B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | 1.0 mg |
[Gln11] b-Amyloid (1-40) | 62-0-79A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 0.5 mg |
[Gln11] b-Amyloid (1-40) | 62-0-79B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 1.0 mg |
[Gln22] ßAmyloid (1-40) | 62-0-89A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 0.5 mg |
[Gln22] ßAmyloid (1-40) | 62-0-89B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 1.0 mg |
[Gly21] β-Amyloid (1-40) | 62-0-61A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Gly-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 0.5 mg |
[Gly21] β-Amyloid (1-40) | 62-0-61B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Gly-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 1.0 mg |
[Gly22] β-Amyloid (1-40) | 62-0-24A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 0.5 mg |
[Gly22] β-Amyloid (1-40) | 62-0-24B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 1.0 mg |
[Lys22] b-Amyloid (1-40) | 62-0-91B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Lys-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 1.0 mg |
[Lys22] b-Amyloid (1-40) | 62-0-91A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Lys-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 0.5 mg |
[Nle35] b-Amyloid (1-40) | 62-0-26A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Nle-Val-Gly-Gly-Val-Val | 0.5 mg |
[Nle35] b-Amyloid (1-40) | 62-0-26B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Nle-Val-Gly-Gly-Val-Val | 1.0 mg |
[Phe10] b-Amyloid (1-40) | 62-0-2 | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Phe-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 0.5 mg |
[Phe10] b-Amyloid (1-40) | 62-0-25B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Phe-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | 1.0 mg |
ß-Amyloid (1-24) | 62-0-11A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val | 0.5 mg |
ß-Amyloid (1-24) | 62-0-11B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val | 1.0 mg |
ß-Amyloid (1-46) | 62-0-59A | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-Val-Ile-Val | 0.5 mg |
ß-Amyloid (1-46) | 62-0-59B | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-Val-Ile-Val | 1.0 mg |
目錄多肽：
A
血管緊張素轉換酶抑制劑ACE Inhibitors
激脂激素 Adipokinetic Hormones
促腎上腺皮質(zhì)激素（ ACTH ） Adrenocorticotropic Hormones (ACTH)
腎上腺髓質(zhì)素 Adrenomedullins
刺鼠相關肽 Agouti Related Peptides
咽側體抑制素[抑制保幼激素的分泌] Allatostatins
支鏈淀粉Amylins
淀粉樣蛋白＆相關肽 Amyloids & Related Peptides
血管緊張素 Angiotensins
抗炎肽 Anti-Inflammatory Peptides
抗生素肽 Antibiotic Peptides
抗菌肽 Antimicrobial Peptides
抗氧化肽 Antioxidant Peptides
Apelin的肽 Apelin Peptides
細胞凋亡及相關肽Apoptosis & Related Peptides
心房利鈉肽 Atrial Natriuretic Peptides
B
囊細胞肽 Bag Cell Peptides
大內(nèi)皮素及類似物 Big Endothelin & Analogs
蛙皮素 Bombesins
骨鈣蛋白 Bone Gla Proteins
緩激肽 Bradykinins
腦利鈉肽（ BNP）Brain Natriuretic Peptides (BNP)
C
C-肽 C-Peptides
C-型利鈉肽 C-Type Natriuretic Peptides
降鈣素及降鈣素基因相關肽 Calcitonin & Calcitonin Gene Related Peptides (CGRP).
鈣蛋白酶抑制劑 Calpain Inhibitors
酪啡肽Casomorphins
組織蛋白酶及相關肽 Cathepsins & Related Peptides
氯甲基酮 Chloromethylketones
縮膽囊素（膽囊收縮素）Cholecystokinins (CCK)
芋螺毒素及其他毒素Conotoxins & Other Toxins
促腎上腺皮質(zhì)激素釋放因子Corticotropin Releasing Factors
皮質(zhì)醇穩(wěn)定蛋白 Cortistatins
D
防御素 Defensins
強啡肽 Dynorphins
E
內(nèi)嗎啡肽Endomorphins
內(nèi)啡肽 Endorphins
內(nèi)皮抑素 Endostatins
內(nèi)皮素-1及類似物Endothelin-1 & Analogs
內(nèi)皮素-2 ，內(nèi)皮素-3及類似物Endothelin-2, Endothelin-3 & Analogs
內(nèi)皮素及相關肽Endothelins & Related Peptides
腦啡肽Enkephalins
唾液素 Exendins
F
纖連蛋白和細胞外基質(zhì)相關多肽 Fibronectin and Extra Cellular Matrix Related Pept...
FMRF及類似物 FMRF & Analogs
G
甘丙素 Galanins
抑胃肽 Gastric Inhibitory Peptides
胃泌素 Gastrins
饑餓激素Ghrelins
胰高血糖素和胰高血糖素樣肽 Glucagons and Glucagon-Like Peptides
促性腺激素釋放激素相關肽 GnRH Associated Peptides
生長因子片段 Growth Factor Fragments
生長激素和生長激素釋放因子 Growth Hormone & Growth Hormone Releasing Factors（GHRF）
GTP結合蛋白片段 GTP-Binding Protein Fragments
鳥苷素Guanylins
I
昆蟲神經(jīng)肽 Insect-Neuropeptides
L
層粘連蛋白肽 Laminin Peptides
瘦素肽片段 Leptin Fragment Peptides
白細胞激肽及類似物 Leucokinin & Analogs
促黃體激素釋放因子及類似物 LH-RH & Analogs
M
肥大細胞脫顆粒肽 Mast Cell Degranulating Peptides
黑色素濃集激素（ MCH ）Melanin Concentrating Hormone (MCH)
黑素細胞刺激素（ MSH ）Melanocyte Stimulating Hormones (MSH)
黑色素瘤肽 Melanoma peptides
雜項肽 Miscellaneous Peptides
基質(zhì)金屬蛋白酶基質(zhì) MMP Substrates
Motilins
髓磷脂少突膠質(zhì)細胞糖蛋白（MOG ）肽 Myelin Oligodendrocyte Glycoprotein (MOG) Peptide
N
神經(jīng)內(nèi)分泌調(diào)節(jié)肽 Neuroendocrine Regulatory Peptides
神經(jīng)激肽 Neurokinins
神經(jīng)調(diào)節(jié)肽 Neuromedins
神經(jīng)肽W- 23及類似物Neuropeptide W-23 and Analog
神經(jīng)肽Y及類似物 Neuropeptide Y & Analogs
神經(jīng)肽及相關肽 Neuropeptides & Related Peptides
神經(jīng)降壓素Neurotensins
O
阿片類藥物相關肽Opioid Related Peptides
食欲素 Orexins
催產(chǎn)素Oxytocins
P
胰抑素及相關肽 Pancreastatin & Related Peptides
胰多肽 Pancreatic Polypeptides
胰多肽及相關肽 Pancreatic Polypeptides & Related Peptides
甲狀旁腺激素及類似物（ PTH ）Parathyroid Hormone & Analogs (PTH)
肽YY Peptides YY
肽酶底物Petidase Substrates
鬼筆（毒）環(huán)肽Phalloidins
垂體腺苷酸環(huán)化酶激活肽 Pituitary Adenylate Cyclase Activating Peptides (PACAP)
催乳素釋放肽 Prolactin Releasing Peptide
蛋白酶抑制劑 Protease Inhibitor
蛋白激酶及相關肽 Protein Kinase and Related Peptides
R
腎素底物及抑制劑 Renin Substrates & Inhibitors
S
毒素肽 Sarafotoxins
分泌素 Secretins
信號轉導試劑 Signal Transduction Reagents
生長抑素 (促生長素抑制素)及類似物 Somatostatins & Analogs
頂壓素相關肽 Stresscopin Related Peptides
P物質(zhì)及相關肽 Substance P & Related Peptides
底物和酶抑制劑Substrate & Enzyme Inhibitors
T
TAT蛋白 TAT Proteins
血凝素相關&（蛋白酶激活受體）AP多肽 Thrombin Related & (PAR) AP peptides
血小板反應蛋白 Thrombospondin
血小板反應蛋白-I（ TS-I ）細胞結合區(qū) Thrombospondin-I (TS-I) Cell Binding Domain
胸腺生成素和胸腺素肽Thymopoietin & Thymosin Peptides
促甲狀腺激素釋放激素（TRH） Thyrotropin-Releasing Hormones (TRH)
U
尿皮素 Urocortins
尿緊張素 Urotensins
V
血管活性腸肽 Vasoactive Intestinal Peptides (VIP)
血管緊張素 Vasopressins
病毒相關多肽 Virus Related Peptides
非專li多肽：
人胰高血糖素 Glucagon, human
亮丙瑞林 Leuprolide
奧曲肽 Octreotide
夫替瑞林[垂體激素釋放興奮藥] Fertirelin
鮭魚降鈣素Calcitonin, salmon
人/大鼠促腎上腺皮質(zhì)激素釋放因子 Corticotropin Releasing Factor, human, rat
人腦利鈉肽 Brain Natriuretic Peptide, human
胸腺五肽（TP-5） Thymopentin (TP-5)
促腎上腺皮質(zhì)激素（ACTH） corticotropin (ACTH)
依降鈣素Elcatonin
曲普瑞林[抗腫瘤藥] 曲普瑞林 Triptorelin
布舍瑞林[促黃體素釋放激素]Buserelin
胸腺素α-1 Thymosin a-1
生長抑素14 Somatostatin 14
唾液素（9-39）Exendin (9-39)
地址：上海浦東川沙鎮(zhèn)川沙路6619號上海起發(fā)實驗試劑有限公司
郵箱：xs1@78bio.com
傳真：021-50724961
電話
QQ咨詢
4006551678
當前位置：